INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2003

Over-the-counter antacids are the main source of human aluminium exposure, while European patient leaflets vary widely in toxicity warnings.

This review notes that aluminium toxicity, initially linked to bone and brain disorders in chronic renal failure, can occur via dialysis fluids, parenteral nutrition, and oral medications like antacids and phosphate binders. Over-the-counter antacids represent the most important quantitative source of human aluminium exposure, with potential neurotoxic as well as embryonic and fetal toxic effects. However, European patient information leaflets for over-the-counter antacids differ substantially in their warnings, including those regarding increased absorption from concomitant citrate-containing beverages and use during pregnancy.

Study type
Narrative review
Who was studied
Not applicable (narrative review of human and animal studies)
What was measured
Sources of aluminium toxicity and consistency of warnings in OTC antacid leaflets

THE PAPER

Aluminium in over-the-counter drugs: risks outweigh benefits?

Reinke CM, Breitkreutz J, Leuenberger H. Drug Saf, 2003.

PubMed 14583063 ↗DOI 10.2165/00002018-200326140-00003 ↗

Nutrients & adequacyKidney healthBrain & moodBones & musclesFood safety & contaminants

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.